| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, 10% Owner | Chief Executive Officer | Director
3 companies
Riggs Rory B serves as a Director, 10% Owner at CBUS and has filed Form 4s across 3 companies. Across recent SEC filings that breaks down to 3 buys and 49 sells. Those positions are worth an estimated $22.4M at current prices.
Historically, Riggs Rory B's trades have earned a middling insider score of 67/100 across 29 rated trades. Over a 12-month horizon, 65.5% of those trades were profitable, with an average 12-month return of +6.2%.
The biggest single holding is CBUS (~$22.4M) as Director, 10% Owner. Net of sales, the recent Form 4 record there shows accumulation of 518,107 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 20, 2022 | RPRX Royalty Pharma Plc | Director | Sell | 150,000 | $39.42 | $5,913,306.17 | -24.9% | +12.2% | -14.0% | |
| Mar 29, 2022 | RPRX Royalty Pharma Plc | Director | Sell | 60,000 | $38.59 | $2,315,322.00 | -9.1% | +11.1% | -4.4% | |
| Mar 21, 2022 | RPRX Royalty Pharma Plc | Director | Sell | 169,089 | $39.43 | $6,667,520.87 | -100% | +3.4% | -8.5% | |
| Dec 29, 2021 | RPRX Royalty Pharma Plc | Director | Sell | 184,448 | $40.12 | $7,400,767.20 | -23.7% | -2.6% | +0.8% | |
| Nov 17, 2021 | RPRX Royalty Pharma Plc | Director | Sell | 214,389 | $42.34 | $9,076,491.96 | -16.1% | -4.7% | +1.9% | |
| Sep 29, 2021 | RPRX Royalty Pharma Plc | Director | Sell | 128,425 | $36.51 | $4,688,288.01 | -5.8% | +10.4% | +11.9% | |
| Jun 29, 2021 | RPRX Royalty Pharma Plc | Director | Sell | 1,314,912 | $42.11 | $55,370,133.90 | -27.6% | -9.3% | +4.2% | |
| Jun 7, 2021 | RPRX Royalty Pharma Plc | Director | Sell | 273,650 | $45.26 | $12,385,399.00 | -11.6% | -15.7% | -9.5% | |
| Oct 20, 2020 | RPRX Royalty Pharma Plc | Director | Sell | 463,200 | $42.00 | $19,454,400.00 | - | - | - | |
| Jun 18, 2020 | RPRX Royalty Pharma Plc | Director | Buy | 15,000 | $28.00 | $420,000.00 | New | - | - |